Shocking report reveals NHS medical negligence liabilities have quadrupled to £60 billion - exceeding Britain's nuclear decommissioning costs and creating one of government's largest financial burdens.
Exclusive investigation reveals how a toxic blame culture within the NHS is driving staff to breaking point and compromising patient care across Britain.
Exclusive research reveals Londoners are losing confidence in the NHS, with growing concerns about waiting times, staff shortages and mental health services.
Groundbreaking weight loss injections Wegovy and Mounjaro are transforming obesity treatment in the UK, offering new hope for thousands struggling with weight management through both NHS and private healthcare providers.
Groundbreaking research shows obesity injections like Mounjaro and Wegovy deliver unprecedented weight loss results, potentially transforming NHS treatment approaches and offering new hope for millions struggling with weight management.
Groundbreaking research reveals nearly 5% of UK adults are turning to revolutionary weight loss injections like Wegovy and Mounjaro, with overwhelming majority paying privately amid NHS supply constraints.
Groundbreaking research shows weight loss injections like Wegovy and Ozempic do more than help shed pounds - they're linked to significant reductions in premature death from cancer, heart disease and diabetes.
Exclusive: A top NHS consultant reveals how overwhelmed hospitals are failing patients and why government promises aren't matching reality on the ground.
Thousands of NHS workers across England have overwhelmingly voted for strike action, citing deep-rooted institutional racism and significant pay disparities affecting ethnic minority staff.
Groundbreaking medical imaging uncovers alarming side effects of popular weight-loss drugs Ozempic and Wegovy that patients need to know about.
New medical research reveals the sobering reality for patients discontinuing popular weight loss injections like Ozempic and Wegovy, with most regaining significant weight within months.
The NHS is set to undergo a transparency revolution as new performance league tables will rank every trust in England from 2025, revealing critical patient safety risks and care quality variations.
Exclusive: Ambitious government proposals to transform NHS England face significant delays and opposition, with key reforms now in jeopardy as implementation timeline stretches indefinitely.
Groundbreaking new research reveals how medications like Ozempic, Wegovy, Mounjaro and Zepbound are creating unprecedented weight loss opportunities this autumn, potentially reshaping public health approaches to obesity nationwide.
Breakthrough research shows Mounjaro users lost significantly more weight than Wegovy patients in head-to-head comparison, potentially reshaping obesity treatment across the UK.
As the Labour government unveils sweeping NHS reforms, experts and insiders question the lack of a concrete delivery plan. This analysis examines the funding, staffing, and logistical challenges threatening to derail the ambitious health service overhaul.
Exclusive investigation reveals the soaring financial and human cost of new obesity drugs. As millions rely on Wegovy and Ozempic, the NHS faces a multi-billion pound dilemma when patients stop treatment and weight returns.
Exclusive: The NHS faces a financial timebomb as new analysis reveals prescribing weight-loss drugs like Wegovy could cost twice the entire current GP prescribing budget, sparking a national rationing debate.
Exclusive: NHS England's new Integrated Care Boards are cutting hundreds of jobs despite promises of improved healthcare, triggering union outrage and patient safety concerns as financial pressures mount.
Exclusive: The Royal College of Physicians delivers a stark warning to the UK government, stating the NHS is at breaking point and requires urgent intervention to prevent systemic collapse.
A major UK trial reveals the new semaglutide pill, a potential game-changer in obesity treatment, leads to significant weight loss, offering a powerful alternative to injections.
Groundbreaking research reveals that blockbuster weight-loss jabs do more than suppress appetite—they may fundamentally change the brain's response to food, offering new hope for tackling compulsive eating disorders.
New research reveals that GLP-1 weight-loss injections not only aid in shedding pounds but also significantly quiet intrusive thoughts about food, offering a dual benefit for patients.
A damning new report warns that government plans to rank NHS hospitals in competitive 'league tables' will cripple collaboration, demoralise staff, and ultimately harm patient care across the UK.
Groundbreaking NHS research reveals obesity injections like Wegovy are dramatically more effective than lifestyle changes alone for teenagers, offering new hope in the childhood obesity crisis.
Groundbreaking UK research suggests GLP-1 weight-loss injections, including Wegovy, may dramatically reduce the risk of obesity-related cancers, offering new hope in preventative oncology.
Good Morning Britain's Ranvir Singh was visibly moved during an emotional interview with a bereaved mother protesting outside Parliament. The powerful exchange highlighted the human cost of NHS waiting times and staffing shortages.
The NHS is rolling out a powerful new 4mg weekly injection of semaglutide, a 'game-changer' in weight loss treatment, as part of a major strategy to tackle the nation's obesity epidemic.
The NHS receives a powerful new weapon in the fight against obesity as medical regulators approve a higher 2.4mg dose of Wegovy, proven to help patients shed significantly more weight.
Exclusive analysis reveals the NHS is grappling with its most severe crisis as waiting lists soar to a record high and A&E performance plummets to its lowest level. Experts warn of a 'perfect storm' threatening patient care.